The pervasive dysregulation of pseudogenes across cancer types—with some functioning as tumor suppressors (e.g., PTENP1) and others as oncogenic drivers (e.g., KRASP1, BRAFP1)—highlights their importance as a novel class of cancer genes. This evidence concerns the gene BRAFP1 and cancer.